Login:

username:
password:

New to sessions.thyroid.org?

Create Account

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Conference

Do I Have Access?

Access:

Availability:

Browse by: Sort by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 137
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Autoimmunity
Sandra M. McLachlan, PhD
Cedars-Sinai Medical Center, Los Angeles, CA
from 15th International Thyroid Congress on October 18, 2015 5:45 PM-7:30 PM
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Thyroid Cancer Neoplasm
Martin Schlumberger, MD
Institute Gustave-Roussy, Villejuif 94805 Cedex, France
from 15th International Thyroid Congress on October 18, 2015 5:45 PM-7:30 PM
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Clinical Thyroidology
David S. Cooper
Johns Hopkins University School of Medicine, Baltimore, MD
from 15th International Thyroid Congress on October 18, 2015 5:45 PM-7:30 PM
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Targeted Therapeutic Agents for MTC
Rossella Elisei, MD
University of Pisa, Pisa 56124, Italy
from 15th International Thyroid Congress on October 19, 2015 7:00 AM-8:20 AM
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Update on MTC Guidelines
Samuel A. Wells, Jr., MD
National Cancer Institute NIH, Bethesda, MD
from 15th International Thyroid Congress on October 19, 2015 7:00 AM-8:20 AM
Opening Plenary Session: Advancing Individualized Medicine with Public–Private Partnerships
William W. Chin, MD
PhRMA, Washington, DC
from 15th International Thyroid Congress on October 19, 2015 8:35 AM-9:20 AM
Symposium: New Concepts in the Management of Thyroid Nodules
Epidemiology of Benign Thyroid Nodules
Shuhang Xu, MD
Nanjing University of Traditional Chinese Medicine, Nanjing, Peoples Republic of China
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
Symposium: Nontraditional TSHR Signaling
Selective TSHR Signaling by TSHR Antibodies
Terry F. Davies, MD, FRCP
Mount Sinai School of Medicine, New York, NY
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
Symposium: TR Alpha Mutations – Bench to Bedside
Human Mutations
Carla Moran, MB, ChB
University of Cambridge, Cambridge, United Kingdom
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
Symposium: TR Alpha Mutations – Bench to Bedside
Treatment of Patients
Robin P. Peeters, MD, PhD
Erasmus MC, Rotterdam, Rotterdam, Netherlands
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Redifferentiation of RAI–Refractory Thyroid Cancer
James A. Fagin, MD
Memorial Sloan-Kettering Cancer Center, New York, NY
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Targeted Therapy
Sophie Leboulleux, MD, PhD
Service De Medecine Nucleair Et De Cancerologie Endocrinienne Institut, Villejuif, France
from 15th International Thyroid Congress on October 19, 2015 9:45 AM-11:00 AM
DD1 – Discussion/Debates Clinical: A Case-Based Discussion of International Hypothyroidism Guidelines
Jacqueline Jonklaas, MD
Georgetown University Medical Center, Washington, DC
from 15th International Thyroid Congress on October 19, 2015 11:00 AM-11:50 AM
DD2 – Discussion/Debates Clinical: Targeted Therapy for Thyroid Cancer: When and What?
Steven I. Sherman, MD
The University of Texas M. D. Anderson Cancer Center, Houston, TX
from 15th International Thyroid Congress on October 19, 2015 11:00 AM-11:50 AM
DD2 – Discussion/Debates Clinical: Targeted Therapy for Thyroid Cancer: When and What?
Johannes W.A. Smit, MD, PhD, FRCP
Radboud University Medical Center, Nijmegen, Netherlands
from 15th International Thyroid Congress on October 19, 2015 11:00 AM-11:50 AM
DD5 – Discussion/Debates Clinical: Is There a Role for Long-Term Anti-Thyroid Drug Therapy?
Douglas S. Ross, MD
Massachusetts General Hospital, Boston, MA
from 15th International Thyroid Congress on October 19, 2015 11:00 AM-11:50 AM
DD5 – Discussion/Debates Clinical: Is There a Role for Long-Term Anti-Thyroid Drug Therapy?
Stig Andersen, MD, PhD, PGCME
Aalborg University Hospital, Aalborg, Denmark
from 15th International Thyroid Congress on October 19, 2015 11:00 AM-11:50 AM
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Pregnancy
Alex S. Stagnaro-Green, MD, MHPE
University of Illinois College of Medicine At Rockford, Rockford, IL
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Hashimoto's Thyroiditis
Mario Rotondi
University of Pavi, Italy
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Graves' Disease
Eijun Nishihara, MD
Kuma Hospital, Kobe 8-2-35, Japan
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: Prognostic Assessment of Thyroid Cancer
Clinical Risk Stratification
Furio Pacini
University of Siena, Siena 53100, Italy
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: Prognostic Assessment of Thyroid Cancer
Real Time Prognostication
R. Michael Tuttle, MD
Memorial Sloan-Kettering Cancer Center, New York, NY
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: T4/T3 Combination Therapy for Hypothyroidism
Do Patients Prefer T4/T3 Therapy, and Why?
Colin M. Dayan, MA, MBBS, FRCP, PhD
Cardiff University School of Medicine, Cardiff, United Kingdom
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: T4/T3 Combination Therapy for Hypothyroidism
What is the Mechanism for Enhanced Weight Loss with T3?
Francesco S. Celi, MD
Virginia Commonwealth University, Richmond, VA
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
Symposium: T4/T3 Combination Therapy for Hypothyroidism
Risks/Safety of Combination Therapy
Anne R. Cappola, MD, ScM
University of Pennsylvania School of Medicine, Philadelphia, PA
from 15th International Thyroid Congress on October 19, 2015 1:50 PM-3:05 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 137